Close Menu

NEW YORK – Abingdon Health and Abcam have inked a collaboration and comarketing agreement to identify opportunities for their products and services, including Abcam's reagent portfolio and Abingdon Health’s rapid test contract development and manufacturing services, the firms said on Tuesday.

Under the terms of the agreement, Cambridge, UK-based Abcam will be the preferred supplier of gold nanoparticles and custom conjugation reagents and services for lateral flow assays developed by York, UK-based Abingdon.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.